Oura to Acquire Medical AI Startup Counsel Health for $625 Million

Oura announced in November 2026 that it has agreed to acquire Counsel Health, a medical AI chatbot startup, for $625 million. The deal was disclosed alongside the company’s quarterly earnings and is expected to close before the end of the year.

Counsel Health describes itself as an “AI-native primary care company.” Its platform delivers AI-generated responses and health insights drawn from users’ wearable data, with the option to escalate conversations to in-house physicians. The company’s AI chatbot was added to Oura’s app earlier in 2026 ahead of the acquisition announcement.

Oura CEO Tom Hale told Bloomberg the acquisition is part of a broader plan to connect wearables, clinical AI, and physician access using biometric data to answer health questions and monitor ongoing conditions. The combined offering is intended to focus on three areas: preventative care, acute care for episodic health concerns, and specialty and chronic care — including reproductive and cardiometabolic health.

Counsel Health’s 70 employees will join Oura as part of the transaction. Counsel CEO Muthu Alagappan will become Oura’s chief clinical AI officer. Alagappan also told Bloomberg the company plans to expand its physician network, which currently consists of about 50 on-demand doctors.

Oura says Counsel Health will continue operating its medical AI platform beyond Oura’s own user base, serving enterprise partners such as health plans, health systems, consumer health organizations, and employers.

The deal suggests Oura is moving beyond fitness tracking toward a broader healthcare model, potentially positioning its ring hardware as a gateway to clinical services — though the full scope of that integration will depend on how the two companies combine their platforms after closing.